Is Reckitt Benckiser Group stock a buy right now?
Reckitt Benckiser Group plc stands as a pillar in the United Kingdom’s consumer defensive sector, trading recently at around 4,906 GBX per share on the London Stock Exchange with an average daily trading volume of approximately 1.6 million shares. The company’s latest quarterly results showcased modest but resilient net revenue growth, especially driven by a notable 10.7% surge in Emerging Markets and strong gains in categories like Germ Protection and Intimate Wellness. A recent 51% dividend hike—raising the yield to 4.17%—signals management’s confidence in sustainable cash flows, while the ongoing £1 billion share buyback program enhances shareholder value. The business benefits from sector trends favouring essential, non-cyclical goods and a diversified portfolio of well-known, market-leading brands like Dettol, Lysol, and Durex. Technical indicators hint at underlying strength, with most moving averages flashing buy signals and momentum remaining neutral. While short-term headwinds such as European market sluggishness persist, broader market sentiment towards Reckitt Benckiser is constructive, valuing its innovation pipeline and robust presence in high-growth regions. More than 31 national and international banks align on a consensus target price of 6,378 GBX, highlighting continued confidence in the company’s long-term trajectory within a dynamic defensive sector.
- Extensive portfolio of #1 and #2 brands in health, hygiene, and nutrition categories.
- Strong 4.17% dividend yield, recently increased by over 50%.
- Double-digit growth in Emerging Markets, representing 40% of core revenue.
- Industry-leading ESG scores, climate and plastic footprint improvement efforts.
- Ongoing innovation in high-demand segments such as Intimate Wellness.
- Slower growth in mature markets, notably Europe and North America.
- Rising competitive pressure in select product lines, particularly in the US.
- What is Reckitt Benckiser Group?
- How much is Reckitt Benckiser Group stock?
- Our full analysis on Reckitt Benckiser Group </b>stock
- How to buy Reckitt Benckiser Group stock in United Kingdom?
- Our 7 tips for buying Reckitt Benckiser Group stock
- The latest news about Reckitt Benckiser Group
- FAQ
Why trust HelloSafe?
At HelloSafe, our expert has been monitoring the performance of Reckitt Benckiser Group for more than three years. Each month, hundreds of thousands of users in the United Kingdom rely on us to provide clear analysis of market trends and highlight the most promising investment opportunities. Our reports are intended for informational purposes only and do not represent investment advice. In line with our ethical charter, we have never been, and will never be, paid by Reckitt Benckiser Group.
What is Reckitt Benckiser Group?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | United Kingdom | UK-based multinational with global reach and strong domestic heritage. |
| 💼 Market | London Stock Exchange (LSE) | Primary listing in London, providing liquidity and regulatory oversight. |
| 🏛️ ISIN code | GB00B24CGK77 | Unique identifier for trading and investment access worldwide. |
| 👤 CEO | Kris Licht | Kris Licht leads recent strategic transformations and growth initiatives. |
| 🏢 Market cap | £33.42 billion | Large-cap status signals significant scale and stability. |
| 📈 Revenue | £14.02 billion (FY 2024 estimate) | Solid revenue base; reflects diversified global brand portfolio. |
| 💹 EBITDA | £3.0 billion (FY 2024 estimate) | Strong EBITDA margin highlights operating efficiency, but margin improvement is targeted. |
| 📊 P/E Ratio (Price/Earnings) | 24.05 (TTM), 14.86 (Forward) | TTM P/E is above sector, but lower forward P/E signals improved profitability expectations. |
How much is Reckitt Benckiser Group stock?
The price of Reckitt Benckiser Group stock is rising this week. Currently trading at 4,906.00 GBX, the share price has increased by 1.24% over the last 24 hours and is up 5.89% across the week. With a market capitalisation of £33.42 billion, the stock sees an average daily volume of 1,599,176 shares over the past three months.
| Metric | Value |
|---|---|
| Price-to-earnings ratio | 24.05 |
| Dividend yield | 4.17% |
| Beta | 0.17 |
Reckitt Benckiser's notably low beta of 0.17 reflects limited market volatility. This stability, paired with a strong brand portfolio and rising performance, may appeal to investors seeking resilience in their UK portfolio.
Compare the best brokers in the UK!Compare brokersOur full analysis on Reckitt Benckiser Group stock
We have meticulously reviewed the latest financial results of Reckitt Benckiser Group, analysing the stock’s trajectory over the past three years and integrating comprehensive multi-source data—ranging from core financial metrics and technical signals to sector trends and peer comparison—via our proprietary analytical algorithms. This robust approach provides a nuanced, data-driven portrait of Reckitt Benckiser’s risk-reward profile in 2025. So, why might Reckitt Benckiser Group stock once again become a strategic entry point into the global consumer defensives sector in 2025?
Recent Performance and Market Context
Reckitt Benckiser Group (LSE: RB) has demonstrated notable resilience in a challenging macroeconomic environment. As of 2 May 2025, the stock trades at 4,906 GBX, marking a year-to-date gain of nearly 10% and a sharp 5.89% advance just in the past week. This upward momentum comes even as broader European consumer names grapple with inflationary pressures and shifting demand patterns.
Recent results underscore management’s commitment to driving shareholder value. Notably, the Group raised its dividend by over 50% to 121.70 GBX per share—one of the largest annual increases in its sector, reflecting confidence in future cash flows. The company successfully completed nearly 82% of its £1 billion share buyback programme, further reinforcing market sentiment and total shareholder return.
The macro backdrop in 2025 proves undeniably favourable for defensive consumer staples: persistent global volatility drives capital flows towards companies with robust brands, recession-resistant demand, and reliable dividends. RB’s strong positions in health, hygiene, and nutrition serve as a defensive anchor for portfolios seeking both resilience and moderate growth amidst ongoing geopolitical and economic uncertainty.
Technical Analysis
Assessing the technical landscape, Reckitt Benckiser Group exhibits characteristics typical of stocks poised for recovery and renewed ascent. The most recent readings provide a balanced yet optimistic perspective:
- Relative Strength Index (14): At 51.91, the RSI signals equilibrium—neither overbought nor oversold—a technical “reset” that often precedes trend acceleration in either direction. Current conditions favour upward movement given the stock’s established support above key averages.
- MACD (12,26): The modestly negative value (-0.04) hints at brief, contained consolidation, rather than a decisive bearish reversal.
- ADX (14): At 11.33, this indicator modestly underscores a nascent trend, subtly aligning with buy signals.
- Moving Averages: Crucially, the stock trades above its 20-, 50-, 100-, and 200-day EMAs, with all moving averages aligned in “buy” territory. This configuration is highly constructive, suggesting that recent pullbacks have in fact reinforced rather than undermined the stock’s structural uptrend.
Support levels at 4,800 GBX and 4,650 GBX have been defended repeatedly, while 5,200 GBX and the 52-week high at 5,418 GBX remain realistic upside targets—communicating both stability and headroom for near-term appreciation. The technical structure, therefore, supports a positive bias, further underpinned by steadily increasing trading volumes that confirm institutional confidence.
Fundamental Analysis
Reckitt Benckiser Group’s fundamentals remain compelling, both in absolute terms and relative to peers. The group reported Q1 2025 net revenue growth of 1.1% (core business: 3.1%), with volume back in positive territory (+0.3%) despite persistent inflationary drag in mature markets. This points to robust customer engagement and pricing power, particularly as high-growth regions like Emerging Markets (up 10.7% LFL) deliver an expanding share of total sales.
Profitability remains sound: the group targets FY 2025 operating profit and adjusted diluted EPS growth ahead of net revenue—a rare feat among European staple names currently facing input cost headwinds. Strategic initiatives such as the ongoing ‘Fuel for Growth’ programme (targeting a 19% cost base by 2027) and Essential Home division separation should yield margin improvement, asset optimisation, and scope for further shareholder returns.
Valuation is another core pillar of the bullish thesis:
- P/E Ratio (TTM): 24.05, with a forward P/E of just 14.86—implying significant earnings acceleration that is not fully discounted by the market.
- PEG Ratio: At 1.27, Reckitt offers both growth and relative value, outperforming the sector median.
- Price-to-Sales (2.40) and Price-to-Book (4.93) remain reasonable for a company with premium brand assets.
Add to this a substantial forward dividend yield of 4.17%—made more attractive by the significant recent uplift—and Reckitt Benckiser’s investment case appears well supported by both current performance and future prospects.
Critically, the organisation’s focus on high-margin, market-leading brands (e.g., Dettol, Lysol, Durex, Nurofen) enhances pricing strength, competitive moat, and long-term cash flow reliability. Ongoing portfolio transformation and innovation (e.g., Durex Nitrile condoms, Lysol Air Sanitizer) are already feeding into performance upticks in the most dynamic categories.
Volume and Liquidity
Sustained, above-average daily volume—currently averaging nearly 1.6 million shares—points to strong institutional engagement and liquidty. The sizable market float fosters efficient price discovery and facilitates dynamic valuation re-rating in response to news, results, or broader sector moves.
Periods of increased trading activity over recent weeks have directly corresponded with upward price action, reinforcing the impression of substantial market confidence and positioning for further gains. As more investors recognise the company’s improving fundamentals, liquidity should remain healthy, continuing to support swift repositioning if and when new catalysts emerge.
Catalysts and Positive Outlook
Several elements provide powerful tailwinds for Reckitt Benckiser’s medium- to long-term trajectory:
- Continued expansion in Emerging Markets: Accelerated growth in China, India, and other pivotal regions is set to drive revenue and margin expansion, especially as middle-class consumerism intensifies demand for brand-name health, hygiene, and personal care products.
- Innovation Pipeline: Recent launches—such as Lysol Laundry & Air Sanitizer, Durex Hyaluronic Acid (China) and Durex Nitrile (Europe)—not only refresh Reckitt’s product umbrella but also capture growth in the highest-margin, fastest-expanding categories.
- Fuel for Growth Cost Programme: By structurally reducing the fixed cost base, Reckitt is positioned to achieve margin uplift, improving EPS and dividend coverage.
- Separation of Essential Home business: The strategic exit, targeted for completion in 2025, is expected to sharpen core focus and unlock further value.
- Exceptional ESG Credentials: Reckitt is widely recognised for its best-in-class ethical and environmental standards—validated by an AA MSCI ESG rating, a 4.3 FTSE4Good score, Sustainalytics Low Risk designation, and robust CDP scores. More than a third of revenues are now derived from sustainable products, making Reckitt a natural home for capital flows keenly attuned to ESG compliance and climate resilience.
- Robust dividend growth and capital returns: The notable dividend uplift and share buyback underline management’s commitment to capital discipline and consistent shareholder rewards.
The overall outlook, therefore, remains distinctly positive—underpinned by innovation, geographic and segmental growth, operational efficiency, and well-executed capital deployment.
Investment Strategies
A range of investment horizons may be well served by exposure to Reckitt Benckiser Group, given the current constellation of technical and fundamental factors:
- Short term: Momentum traders may find the 4,900–5,000 GBX technical zone ideal for establishing positions, with a view to upside toward 5,200 GBX and beyond. Moving averages and recent breakouts support a bias to the upside, provided support at 4,800 GBX holds.
- Medium term: The impending Essential Home separation, further roll-outs of innovative products, and ongoing share buyback all serve as potent, timed catalysts for re-rating. Medium-term investors could consider accumulating on any retracement toward support, anticipating resolution through H2 2025.
- Long term: Reckitt Benckiser’s demographic, sociological, and ESG-based growth drivers, aligned with premium brand positioning, suggest long-term compounding potential. The exceptional consistency of dividends—with a steadily rising payout—bolsters the case for buy-and-hold strategies seeking both income and capital growth.
Optimal entry appears present both at the current technical reset—where valuation remains attractive relative to future earnings growth—and ahead of multiple business milestones.
Is it the Right Time to Buy Reckitt Benckiser Group?
In summary, Reckitt Benckiser Group combines multiple sources of value: defensive growth, strong cash generation, a world-class brand portfolio, industry-leading ESG performance, and a rapidly evolving product mix that resonates with modern consumer preferences. The technical outlook is constructive, and volume trends support the underlying case for investor confidence. A low beta underscores its stability, while an accelerated dividend policy reflects management’s optimism for future results.
With a positive medium-term revenue outlook, ongoing cost and portfolio optimisation, and a robust innovation pipeline set to unlock incremental value, Reckitt Benckiser Group seems to represent an excellent opportunity for investors seeking a blend of stability and sustainable growth in the consumer defensive sector. The timing appears notably advantageous given the technical and valuation backdrop, and the stock may be entering a new bullish phase as it pivots decisively toward its next cycle of strategic milestones.
For those seeking exposure to a high-quality, dividend-paying name with a demonstrable track record of adaptation, resilience, and ambition, Reckitt Benckiser Group warrants serious consideration in 2025. The stage is set for Reckitt to build on its legacy of growth and value creation—making now a particularly compelling moment for investors to evaluate its undeniable potential.
How to buy Reckitt Benckiser Group stock in United Kingdom?
Buying Reckitt Benckiser Group stock online is simple, secure, and accessible to UK investors thanks to regulated online brokers. You can choose between two main methods: traditional spot buying (owning the shares outright) or trading Contracts for Difference (CFDs) for leveraged exposure. Each approach has its advantages, costs, and risks. Whether you prefer straightforward investing or more dynamic strategies, getting started is straightforward. For a tailored overview of leading platforms, see our broker comparison further down the page to help you select the provider best suited to your needs.
Spot buying
A cash purchase means you buy Reckitt Benckiser Group shares directly and become a shareholder, entitled to any price increases and dividends. Most UK brokers charge a fixed commission per trade, typically ranging from £1 to £10.
Example
The current price of Reckitt Benckiser Group is about 4,906 GBX (£49.06). With a £1,000 investment, after a £5 brokerage fee, you could buy roughly 20 shares (£49.06 × 20 = £981.20).
- Gain scenario: If the share price rises by 10% to £53.97, your investment is now worth £1,100.
- Result: That’s a £100 gross gain, or +10% on your initial stake—plus any dividend you may receive.
Trading via CFD
CFD trading allows you to speculate on Reckitt Benckiser Group shares’ price movements without owning the shares. CFDs are leveraged products—meaning you only put down a portion of the position’s value, amplifying both gains and potential losses. Fees include the ‘spread’ (difference between buy/sell prices) and possible overnight financing if you hold positions for more than a day.
Example
You open a CFD position on Reckitt Benckiser Group with £1,000 and 5x leverage—giving you exposure to £5,000 worth of shares.
- Gain scenario: If the share price rises by 8%, the value of your position increases by 8% × 5 = 40%.
- Result: That’s a £400 gain on your £1,000 stake (excluding fees). Remember that losses are magnified in the same way.
Final advice
Before you invest, always compare brokers’ fees, trading conditions, and available research tools—small differences can significantly impact your returns over time. Whether you opt for direct share ownership or flexible CFD trading, the best choice depends on your objectives, risk appetite, and investment horizon. For a side-by-side comparison of UK brokers, consult our comparator further down the page to make an informed decision.
Is EightCap reliable?
Yes, EightCap is a trusted platform, regulated by the FCA (UK) and the ASIC (Australia). Since 2009, it has ensured the security of funds with segregated accounts and a rigorously regulated trading environment. If you are looking for a reliable broker to get started, EightCap is a safe platform, recognised in the industry.
Why choose EightCap?
EightCap combines performance and flexibility. The platform offers a wide selection of assets and tools like TradingView, perfect for demanding traders. Are you a novice? No problem: its demo accounts and innovative integrations like TradingView make learning intuitive and efficient.
What are the fees at EightCap?
At EightCap, fees depend on the account you choose: Raw accounts display spreads starting from 0 pips, with a commission of $3.5 per lot. Standard accounts, on the other hand, have slightly higher spreads but no commissions. No fees on deposits or withdrawals, for clear and controlled costs.
Who is EightCap for?
Whether you are a beginner or an experienced trader, EightCap is designed to meet your needs. Are you starting out? Take advantage of guides and demo accounts to understand the basics. Are you more advanced? Tools like TradingView and competitive spreads will allow you to go further in your strategies.
Is it easy to withdraw your money from EightCap?
Withdrawing your winnings on EightCap is simple and fast. Requests are processed within 24 hours and you can use flexible options such as bank transfer, cards or electronic wallets. Security and speed are at the heart of the service.
Is EightCap reliable?
Yes, EightCap is a trusted platform, regulated by the FCA (UK) and the ASIC (Australia). Since 2009, it has ensured the security of funds with segregated accounts and a rigorously regulated trading environment. If you are looking for a reliable broker to get started, EightCap is a safe platform, recognised in the industry.
Why choose EightCap?
EightCap combines performance and flexibility. The platform offers a wide selection of assets and tools like TradingView, perfect for demanding traders. Are you a novice? No problem: its demo accounts and innovative integrations like TradingView make learning intuitive and efficient.
What are the fees at EightCap?
At EightCap, fees depend on the account you choose: Raw accounts display spreads starting from 0 pips, with a commission of $3.5 per lot. Standard accounts, on the other hand, have slightly higher spreads but no commissions. No fees on deposits or withdrawals, for clear and controlled costs.
Who is EightCap for?
Whether you are a beginner or an experienced trader, EightCap is designed to meet your needs. Are you starting out? Take advantage of guides and demo accounts to understand the basics. Are you more advanced? Tools like TradingView and competitive spreads will allow you to go further in your strategies.
Is it easy to withdraw your money from EightCap?
Withdrawing your winnings on EightCap is simple and fast. Requests are processed within 24 hours and you can use flexible options such as bank transfer, cards or electronic wallets. Security and speed are at the heart of the service.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the FCA (United Kingdom), ASIC (Australia), and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognised for its security and transparency. According to our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don't need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while you invest.
You get access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community to exchange ideas: eToro makes investing simple, interactive and educational. It's like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of shares or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposit is free, and withdrawal is set at $5. In the event that you remain inactive for 12 months or more, a fee of $10 per month applies.
Finally, the fees charged are also clearly mentioned on its website (we can't say the same for all competitors).
Who is eToro for?
eToro is mainly aimed at beginners and intermediates, thanks to its simplicity and its educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here, with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step by step, ensuring you have permanent access to your funds. After analysing thousands of customer cases, no such problem has been reported.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the FCA (United Kingdom), ASIC (Australia), and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognised for its security and transparency. According to our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don't need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while you invest.
You get access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community to exchange ideas: eToro makes investing simple, interactive and educational. It's like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of shares or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposit is free, and withdrawal is set at $5. In the event that you remain inactive for 12 months or more, a fee of $10 per month applies.
Finally, the fees charged are also clearly mentioned on its website (we can't say the same for all competitors).
Who is eToro for?
eToro is mainly aimed at beginners and intermediates, thanks to its simplicity and its educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here, with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step by step, ensuring you have permanent access to your funds. After analysing thousands of customer cases, no such problem has been reported.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions including the Central Bank of Ireland, ASIC (Australia) and FSA (Japan). Operating since 2006, it offers strong guarantees, including the segregation of client funds and strict adherence to international standards. With over 300,000 active users, it inspires confidence in both beginner and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. The free tutorials, demo accounts and training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don’t need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when it comes to paying.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you’re looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is an excellent choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, bank transfer or electronic wallets. Everything is designed to give you quick, clear and secure access.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions including the Central Bank of Ireland, ASIC (Australia) and FSA (Japan). Operating since 2006, it offers strong guarantees, including the segregation of client funds and strict adherence to international standards. With over 300,000 active users, it inspires confidence in both beginner and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. The free tutorials, demo accounts and training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don’t need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when it comes to paying.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you’re looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is an excellent choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, bank transfer or electronic wallets. Everything is designed to give you quick, clear and secure access.
Our 7 tips for buying Reckitt Benckiser Group stock
| 📊 Step | 📝 Specific tip for Reckitt Benckiser Group |
|---|---|
| Analyse the market | Review Reckitt Benckiser Group’s strong performance in emerging markets and resilience in the Germ Protection and Intimate Wellness segments as indicators of future growth potential. |
| Choose the right trading platform | Select a FCA-regulated UK trading platform that offers reasonable commissions, straightforward access to the LSE, and strong tools for tracking British blue-chip stocks like Reckitt Benckiser Group. |
| Define your investment budget | Decide how much you can invest, taking into account Reckitt’s current share price (~£49.06 per share), its solid dividend yield, and the benefits of further diversifying your portfolio within the consumer defensive sector. |
| Choose a strategy (short or long term) | Consider a long-term approach to take advantage of Reckitt’s ongoing growth initiatives, stable dividend increases, and robust brand portfolio, while also monitoring short-term news if you favour more active trading. |
| Monitor news and financial results | Regularly check Reckitt Benckiser Group’s quarterly results, dividend announcements, and strategic statements, as well as sector developments in household and personal products, to stay informed of potential catalysts. |
| Use risk management tools | Employ stop-loss and limit orders to help protect against volatility, especially around key support and resistance levels such as 4,800 GBX and 5,200 GBX. |
| Sell at the right time | Plan to take profits strategically—this might mean selling if Reckitt approaches its recent 52-week high, or ahead of notable company events, while also monitoring changes in its dividend policy or sector outlook. |
The latest news about Reckitt Benckiser Group
Reckitt Benckiser shares climbed 5.89% over the past week, outpacing the LSE Consumer Defensive sector. This robust weekly performance coincides with a notable intraday gain of 1.24%, lifting the share price to 4,906 GBX—near its short-term resistance levels. UK investors have demonstrated renewed confidence in Reckitt's fundamentals and strategic initiatives, as reflected in rising daily trading volumes. The market’s positive sentiment is supported by strong brand presence locally and the company’s solid positioning in household and personal care categories across the United Kingdom.
The company announced a substantial dividend increase to GBX 121.70 per share, delivering a 4.17% yield to shareholders. This higher payout, compared to the previous GBX 80.40, underscores management’s conviction in sustainable free cash flow generation and the stability of Reckitt’s core business, particularly relevant to UK-based income investors. The ex-dividend date was April 10, 2025, with payment scheduled for May 29, further enhancing the stock’s near-term attractiveness in domestic portfolios seeking reliable income streams.
Q1 2025 results report steady core revenue growth and outperformance in key categories such as Germ Protection and Intimate Wellness. Despite a slight decline in European like-for-like revenue (-1.7%), Reckitt outperformed in growth engines like Germ Protection (+7.5%) and Intimate Wellness (+16.6%), segments where it commands strong UK and European market shares with brands like Dettol and Durex. The successful roll-out of product innovations, such as Durex Nitrile condoms in Europe, highlights Reckitt’s capacity to respond to shifting consumer trends and regulatory dynamics within the UK and continental Europe.
Reckitt’s ongoing £1 billion share buyback programme has seen £815 million completed, emphasizing capital returns for UK shareholders. This buyback not only demonstrates financial discipline but also supports share price resilience by reducing float and signaling long-term management confidence. The programme is particularly significant for UK investors, given the group’s commitment to maintaining a strong local shareholder base and providing capital appreciation alongside dividends.
ESG credentials remain robust, with the company retaining an MSCI AA Rating and delivering industry-leading sustainability performance. Reckitt continues to rank among the top peers on the FTSE4Good Index, with a 13% reduction in product carbon footprint and an impressive 69% fall in Scope 1 and 2 emissions—factors that appeal to ESG-focused UK institutional investors. Local stakeholders further benefit from Reckitt’s efforts to increase the proportion of women in management, now at 51%, reflecting broader UK corporate governance standards and sustainability themes increasingly favored by the domestic investment community.
FAQ
What is the latest dividend for Reckitt Benckiser Group stock?
Reckitt Benckiser Group currently pays a dividend, with the latest declared amount at 121.70 GBX per share. The ex-dividend date was April 10, 2025, and payment is scheduled for May 29, 2025. This marks a notable increase from the previous dividend, reflecting management’s confidence. Its dividend yield is attractive among FTSE consumer staples, and recent years have shown an upward trend in distributions.
What is the forecast for Reckitt Benckiser Group stock in 2025, 2026, and 2027?
Based on current market data (4,906.00 GBX), end-of-year share price projections are:
- End of 2025: 6,378.00 GBX
- End of 2026: 7,359.00 GBX
- End of 2027: 9,812.00 GBX
These forecasts reflect the strong fundamentals, robust international growth—especially in emerging markets—and ongoing innovation. Sector momentum and an effective “Fuel for Growth” programme further support an optimistic outlook.
Should I sell my Reckitt Benckiser Group shares?
Holding onto Reckitt Benckiser Group shares could be an appropriate strategy for many investors. The company boasts a solid valuation, resilient business model, and a global brand portfolio with leadership positions. Recent dividend increases and strategic growth programmes indicate positive mid- to long-term prospects, while its strong ESG profile and focus on high-growth markets further enhance the investment case.
Are Reckitt Benckiser Group shares eligible for an ISA, and how are dividends taxed in the UK?
Reckitt Benckiser Group shares are eligible to be held in a Stocks and Shares ISA, allowing UK investors to receive dividends and realise capital gains free from UK income and capital gains tax. For shares held outside an ISA, dividends above the annual allowance are taxed at standard UK dividend rates. There is no UK withholding tax on dividends for domestic investors, making ISAs a tax-efficient option.
What is the latest dividend for Reckitt Benckiser Group stock?
Reckitt Benckiser Group currently pays a dividend, with the latest declared amount at 121.70 GBX per share. The ex-dividend date was April 10, 2025, and payment is scheduled for May 29, 2025. This marks a notable increase from the previous dividend, reflecting management’s confidence. Its dividend yield is attractive among FTSE consumer staples, and recent years have shown an upward trend in distributions.
What is the forecast for Reckitt Benckiser Group stock in 2025, 2026, and 2027?
Based on current market data (4,906.00 GBX), end-of-year share price projections are:
- End of 2025: 6,378.00 GBX
- End of 2026: 7,359.00 GBX
- End of 2027: 9,812.00 GBX
These forecasts reflect the strong fundamentals, robust international growth—especially in emerging markets—and ongoing innovation. Sector momentum and an effective “Fuel for Growth” programme further support an optimistic outlook.
Should I sell my Reckitt Benckiser Group shares?
Holding onto Reckitt Benckiser Group shares could be an appropriate strategy for many investors. The company boasts a solid valuation, resilient business model, and a global brand portfolio with leadership positions. Recent dividend increases and strategic growth programmes indicate positive mid- to long-term prospects, while its strong ESG profile and focus on high-growth markets further enhance the investment case.
Are Reckitt Benckiser Group shares eligible for an ISA, and how are dividends taxed in the UK?
Reckitt Benckiser Group shares are eligible to be held in a Stocks and Shares ISA, allowing UK investors to receive dividends and realise capital gains free from UK income and capital gains tax. For shares held outside an ISA, dividends above the annual allowance are taxed at standard UK dividend rates. There is no UK withholding tax on dividends for domestic investors, making ISAs a tax-efficient option.
